Avenda Health

Company profile

About Avenda Health

Avenda Health is a precision medicine company focused on transforming prostate cancer care through artificial intelligence. The company's flagship product, Unfold AI, is an FDA-cleared platform that generates detailed 3D Cancer Estimation Maps (CEMs) to visualize the precise location and extent of prostate cancer within the prostate gland. By analyzing standard-of-care patient data including MRI scans, fusion biopsy results, pathology reports, and PSA levels, Unfold AI significantly outperforms traditional MRI in identifying where cancer resides. Clinical studies demonstrate that physicians using Unfold AI achieve 84% accuracy in identifying cancer extent, and patients treated with Unfold AI margins are 71% more likely to be cancer-free. The platform addresses a critical gap in prostate cancer treatment: without precise cancer mapping, whole-gland treatments lead to urinary and sexual dysfunction in over 50% of patients, while focal therapy without AI guidance leaves 24-49% of patients with residual cancer. Unfold AI supports multiple treatment modalities including active surveillance, prostatectomy, focal therapy, and radiotherapy by providing actionable insights for surgical planning, biopsy guidance, and treatment targeting. The technology is based on over 100,000 patient data points gathered over 10 years of research and validated in multiple peer-reviewed clinical studies. Avenda Health serves urologists, radiation oncologists, and healthcare systems across the United States, working to make precision-guided prostate cancer care accessible to patients nationwide.

Company description · Avenda Health official website